MedPath

Cromolyn Sodium

Cromolyn Sodium Ophthalmic Solution USP, 4% Sterile

Approved
Approval ID

0d30fb0a-e343-426d-8203-5816bd4cec2f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cromolyn Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-1202
Application NumberANDA075282
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cromolyn Sodium
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 14, 2018
FDA Product Classification

INGREDIENTS (6)

CROMOLYN SODIUMActive
Quantity: 40 mg in 1 mL
Code: Q2WXR1I0PK
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cromolyn Sodium - FDA Drug Approval Details